We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Endocyte Dodges Class Action Over Cancer Drug Claims

Law360, New York (January 4, 2016, 9:29 PM EST) -- An Indiana federal judge on Monday quashed a securities class action claiming Endocyte Inc. lied about the effectiveness of a cancer drug tied to a $1 billion deal with Merck &...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Indiana Southern

Nature of Suit

850(Securities/Commodities)

Judge

Subscribers Only

Date Filed

June 23, 2014

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.